✦ LIBER ✦

The influence of measles vaccination on the incidence of otosclerosis in Germany

✍ Scribed by Wolfgang Arnold; Raymonde Busch; Andreas Arnold; Björn Ritscher; Albrecht Neiss; Hans Peter Niedermeyer

Publisher: Springer-Verlag
Year: 2007
Tongue: English
Weight: 432 KB
Volume: 264
Category: Article
ISSN: 0302-9530
DOI: 10.1007/s00405-007-0253-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The influence of maternally derived anti

The influence of maternally derived antibody on the efficacy of further attenuated measles vaccine

✍ K. E. Stewien; V. Barbosa; O. S. de Lima; K. Osiro 📂 Article 📅 1978 🏛 Springer-Verlag 🌐 English ⚖ 513 KB

The influence of serum on the cytopathic

The influence of serum on the cytopathic effect of measles virus

✍ Roberto A. Moura 📂 Article 📅 1962 🏛 Springer Vienna 🌐 English ⚖ 901 KB

Cumulative incidence rates of the mucopo

Cumulative incidence rates of the mucopolysaccharidoses in Germany

✍ F. Baehner; C. Schmiedeskamp; F. Krummenauer; E. Miebach; M. Bajbouj; C. Whybra; 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 121 KB

An outbreak of measles in Saitama City i

An outbreak of measles in Saitama City in 2007. What is the vaccination strategy to eliminate measles in Japan?

✍ Akihiko Kaetsu; Motonobu Miyazaki; Takuya Imatoh; Erika Matsumoto; Yukiko Sakamo 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 343 KB

Underestimation of the incidence of meas

Underestimation of the incidence of measles in a population of french children

✍ D. Gendrel; M. Chemillier-Truong; D. Rodrigue; J. Raymond; O. Bosco; P. Saliou; 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 234 KB

Modeling the impact of imperfect HIV vac

Modeling the impact of imperfect HIV vaccines on the incidence of the infection

✍ E. Massad; F.A.B. Coutinho; M.N. Burattini; L.F. Lopez; C.J. Struchiner 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 385 KB

One concern about HIV vaccine trials is that participants might develop a false sense of security and increase their risk behavior. This fear has (at least partially) impaired the development of extensive clinical trials on HIV vaccines and are, in principle, justified. In this paper, we develop a d